Mogamulizumab for Sézary syndrome: long-term remission with associated autoimmune haemolytic anaemia.

Autor: Lé AM; Department of Dermatology, Unidade Local de Saúde de Santo António, Porto, Portugal., Peixeiro R; Department of Clinical Hematology, Unidade Local de Saúde de Santo António, Porto, Portugal, Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Unidade Local de Saúde de Santo António, Porto, Portugal., Lau C; Laboratory of Cytometry, Department of Hematology, Unidade Local de Saúde de Santo António, Porto, Portugal., Teixeira MDA; Laboratory of Cytometry, Department of Hematology, Unidade Local de Saúde de Santo António, Porto, Portugal., Cabral R; Department of Clinical Hematology, Unidade Local de Saúde de Santo António, Porto, Portugal, Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Unidade Local de Saúde de Santo António, Porto, Portugal, Unit for Multidisciplinary Research in Biomedicine (UMIB), Instituto de Ciências Biomédicas Abel Salazar., Fernandes I; Department of Dermatology, Unidade Local de Saúde de Santo António, Porto, Portugal, Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Unidade Local de Saúde de Santo António, Porto, Portugal, Unit for Multidisciplinary Research in Biomedicine (UMIB), Instituto de Ciências Biomédicas Abel Salazar.
Jazyk: angličtina
Zdroj: European journal of dermatology : EJD [Eur J Dermatol] 2024 Aug 01; Vol. 34 (4), pp. 457-459.
DOI: 10.1684/ejd.2024.4744
Databáze: MEDLINE